Scott Wasserman
Net worth: - $ as of 30/05/2026
Net worth: - $ as of 30/05/2026
Scott M.
Wasserman is Chief Medical Officer at Kailera Therapeutics, Inc. since 2024.
Former roles include Chief Executive Officer at Latigo Biotherapeutics, Inc. from 2019 to 2023, Vice President & Global Development at Amgen, Inc. from 2015 to 2019, and Venture Partner at Frazier Management LLC from 2023 to 2024.
Education includes an undergraduate degree from Haverford College in 1992, a doctorate from Harvard Medical School in 1997, and an undergraduate degree from Stanford University School of Medicine in 2004.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 15/04/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
| Companies | Position | Start |
|---|
| Companies | Position | End |
|---|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Private Equity Investor | 30/09/2024 |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops non-opioid pain medicines | Chief Executive Officer | 31/05/2023 |
| AMGEN INC. | Private Equity Investor | 30/04/2019 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Finance |
Haverford College
Haverford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops non-opioid pain medicines | Health Technology |
Select your edition
All financial news and data tailored to specific country editions